Your browser doesn't support javascript.
loading
Efficacy and safety of oral deferasirox treatment for transfusional iron overload in pure red cell aplasia patients after allogeneic stem cell transplantation.
Shimizu, Ryo; Takeuchi, Masahiro; Sakaida, Emiko; Ohwada, Chikako; Toyosaki, Masako; Machida, Shinichiro; Onizuka, Makoto; Shono, Katsuhiro; Onoda, Masahiro; Saito, Takeshi; Yano, Shingo; Tanaka, Masatsugu; Fujisawa, Shin; Mori, Takehiko; Usuki, Kensuke; Takahashi, Satoshi; Kanamori, Heiwa; Nakaseko, Chiaki; Okamoto, Shinichiro.
  • Shimizu R; Department of Hematology, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan.
  • Takeuchi M; Department of Hematology, Asahi General Hospital, Asahi, Japan.
  • Sakaida E; Department of Hematology, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan. m-takeuchi@faculty.chiba-u.jp.
  • Ohwada C; Department of Hematology, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan.
  • Toyosaki M; Department of Hematology, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan.
  • Machida S; Department of Hematology and Oncology, School of Medicine, Tokai University, Isehara, Japan.
  • Onizuka M; Department of Hematology and Oncology, School of Medicine, Tokai University, Isehara, Japan.
  • Shono K; Department of Hematology and Oncology, School of Medicine, Tokai University, Isehara, Japan.
  • Onoda M; Department of Internal Medicine, Chiba Aoba Municipal Hospital, Chiba, Japan.
  • Saito T; Department of Internal Medicine, Chiba Aoba Municipal Hospital, Chiba, Japan.
  • Yano S; Division of Clinical Oncology and Hematology, Jikei University School of Medicine, Tokyo, Japan.
  • Tanaka M; Division of Clinical Oncology and Hematology, Jikei University School of Medicine, Tokyo, Japan.
  • Fujisawa S; Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.
  • Mori T; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
  • Usuki K; Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.
  • Takahashi S; Division of Hematology, Department of Medicine, School of Medicine, Keio University, Tokyo, Japan.
  • Kanamori H; Department of Hematology, NTT Medical Center, Tokyo, Japan.
  • Nakaseko C; Division of Molecular Therapy, The Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Okamoto S; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
Ann Hematol ; 98(7): 1781-1783, 2019 Jul.
Article en En | MEDLINE | ID: mdl-31119366
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Aplasia Pura de Células Rojas / Transfusión de Eritrocitos / Trasplante de Células Madre Hematopoyéticas / Sobrecarga de Hierro / Deferasirox Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies Límite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Aplasia Pura de Células Rojas / Transfusión de Eritrocitos / Trasplante de Células Madre Hematopoyéticas / Sobrecarga de Hierro / Deferasirox Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies Límite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article